Skip to content
Search

Latest Stories

New registrations stopped: NHSE reviews mental health support for secondary care staff

New registrations stopped: NHSE reviews mental health support for secondary care staff
The halt comes amidst shortage of staff, burnout and high stress as over 111,000 jobs remain unfilled across the NHS.

In a recent development, NHS England (NHSE) has announced a termination of new registrations for secondary care staff accessing the NHS Practitioner Health service, effective from Monday, April 15.

The decision follows after discussions between NHSE and NHS Practitioner Health regarding service arrangements, which took effect on April 1 and has triggered concerns among healthcare professionals and elicited responses from key stakeholders.


Emphasizing a commitment to ensuring sustainable mental health support for all staff groups, NHSE plans to conduct a thorough review in collaboration with the NHS Practitioner Health service.

Additionally, NHSE has assured existing patients registered with the service that they will continue to receive uninterrupted support to conclude their treatment.

While "a wider review" is underway to provide the mental health support needed to the NHS staff, Dr. Navina Evans, NHSE's chief workforce officer, stated:

"Following discussions with Practitioner Health on their current service for secondary care doctors, dentists, and senior NHS staff, we have jointly agreed to extend the service by 12 months for both existing and new patients"

Expressing deep concern, Dr. Sarah Clarke, President of the Royal College of Physicians, penned a letter to NHSE's chief executive and national medical director, urging a reconsideration of the decision to halt new registrations.

Citing mental health as "vital" now more than ever as "42 per cent staff in 2023 felt unwell due to work related stress", she highlighted the challenges faced by healthcare professionals including "staff shortages (over 110 FTE vacancies) and waiting lists at 7.5 million", accentuating the need for continued support.

Furthermore, the decision to halt new referrals during the review process has raised apprehensions about the perceived lack of support for NHS staff.

Saffron Cordrey, deputy chief executive at NHS Providers, also voiced deep concern over the withdrawal of funding for mental health support services for NHS hospital staff by NHS Practitioner Health.

Cordrey emphasized the pressing need for national funding to enhance working conditions and support staff wellbeing, particularly amidst over 111,000 unfilled jobs across the NHS.

As stakeholders engage in dialogue to address these concerns, the focus remains on ensuring the wellbeing and support of NHS staff during these challenging times.

More For You

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less